Genetic Mouse Models as In Vivo Tools for Cholangiocarcinoma Research
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genetic Mouse Models as In Vivo Tools for Cholangiocarcinoma Research
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 12, Pages 1868
Publisher
MDPI AG
Online
2019-11-26
DOI
10.3390/cancers11121868
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- YAP and the Hippo pathway in cholangiocarcinoma
- (2019) Takaaki Sugihara et al. JOURNAL OF GASTROENTEROLOGY
- Hippo Cascade Controls Lineage Commitment of Liver Tumors in Mice and Humans
- (2018) Shanshan Zhang et al. AMERICAN JOURNAL OF PATHOLOGY
- Animal models of cholangiocarcinoma
- (2018) Emilien Loeuillard et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Combination of Kras activation and PTEN deletion contributes to murine hepatopancreatic ductal malignancy
- (2018) Yun-kai Lin et al. CANCER LETTERS
- Kras and Tp53 mutations cause cholangiocyte- and hepatocyte-derived cholangiocarcinoma
- (2018) Margaret A Hill et al. CANCER RESEARCH
- Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma
- (2018) Chirag Nepal et al. HEPATOLOGY
- Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model
- (2018) Mingjie Dong et al. Cell Death & Disease
- Animal models of cholangiocarcinoma: What they teach us about the human disease
- (2018) Massimiliano Cadamuro et al. Clinics and Research in Hepatology and Gastroenterology
- Establishment and analysis of a novel mouse line carrying a conditional knockin allele of a cancer-specific FBXW7 mutation
- (2018) Tsuneo Ikenoue et al. Scientific Reports
- Necroptosis microenvironment directs lineage commitment in liver cancer
- (2018) Marco Seehawer et al. NATURE
- Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
- (2017) Daniela Sia et al. GASTROENTEROLOGY
- Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice
- (2017) Shanshan Zhang et al. JOURNAL OF HEPATOLOGY
- Biliary epithelial injury-induced regenerative response by IL-33 promotes cholangiocarcinogenesis from peribiliary glands
- (2017) Hayato Nakagawa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
- (2017) Apinya Jusakul et al. Cancer Discovery
- Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH -Mutant Molecular Profiles
- (2017) Farshad Farshidfar et al. Cell Reports
- Genetically engineered mouse models in oncology research and cancer medicine
- (2016) Kelly Kersten et al. EMBO Molecular Medicine
- Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma
- (2016) Xueru Mu et al. GASTROENTEROLOGY
- Differential requirement forde novolipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans
- (2016) Lei Li et al. HEPATOLOGY
- Genetic lineage tracing analysis of the cell of origin of hepatotoxin-induced liver tumors in mice
- (2016) Soona Shin et al. HEPATOLOGY
- Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
- (2016) Jesus M. Banales et al. Nature Reviews Gastroenterology & Hepatology
- Notch3 drives development and progression of cholangiocarcinoma
- (2016) Rachel V. Guest et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans
- (2016) L Che et al. Oncogenesis
- A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletion
- (2016) Tsuneo Ikenoue et al. Scientific Reports
- IL-33 facilitates oncogene-induced cholangiocarcinoma in mice by an interleukin-6-sensitive mechanism
- (2015) Daisaku Yamada et al. HEPATOLOGY
- CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice
- (2015) Julia Weber et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver
- (2015) Xiaolei Li et al. Oncotarget
- Hydrodynamic Transfection for Generation of Novel Mouse Models for Liver Cancer Research
- (2014) Xin Chen et al. AMERICAN JOURNAL OF PATHOLOGY
- p53-Dependent Nestin Regulation Links Tumor Suppression to Cellular Plasticity in Liver Cancer
- (2014) Darjus F. Tschaharganeh et al. CELL
- CRISPR-mediated direct mutation of cancer genes in the mouse liver
- (2014) Wen Xue et al. NATURE
- Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer
- (2014) Supriya K. Saha et al. NATURE
- The new frontier of genome engineering with CRISPR-Cas9
- (2014) J. A. Doudna et al. SCIENCE
- Mutational landscape of intrahepatic cholangiocarcinoma
- (2014) Shanshan Zou et al. Nature Communications
- A Critical Role for Notch Signaling in the Formation of Cholangiocellular Carcinomas
- (2013) Steffen Zender et al. CANCER CELL
- Cell Lineage Tracing Reveals a Biliary Origin of Intrahepatic Cholangiocarcinoma
- (2013) R. V. Guest et al. CANCER RESEARCH
- Modeling Pathogenesis of Primary Liver Cancer in Lineage-Specific Mouse Cell Types
- (2013) Ágnes Holczbauer et al. GASTROENTEROLOGY
- Yes-Associated Protein Up-regulates Jagged-1 and Activates the NOTCH Pathway in Human Hepatocellular Carcinoma
- (2013) Darjus Felix Tschaharganeh et al. GASTROENTEROLOGY
- Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
- (2013) Sumera Rizvi et al. GASTROENTEROLOGY
- Adjuvant gemcitabine therapy improves survival in a locally induced, R0-resectable model of metastatic intrahepatic cholangiocarcinoma
- (2013) Engin Gürlevik et al. HEPATOLOGY
- The frequency of KRAS and BRAF mutations in intrahepatic cholangiocarcinomas and their correlation with clinical outcome
- (2013) Scott Robertson et al. HUMAN PATHOLOGY
- PTEN loss and KRAS activation cooperate in murine biliary tract malignancies
- (2013) Victoria Marsh et al. JOURNAL OF PATHOLOGY
- Activation of Notch Signaling Is Required for Cholangiocarcinoma Progression and Is Enhanced by Inactivation of p53 In Vivo
- (2013) Mona El Khatib et al. PLoS One
- Mouse model of intrahepatic cholangiocarcinoma validates FIG-ROS as a potent fusion oncogene and therapeutic target
- (2013) A. Saborowski et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- KrasG12D and p53 Mutation Cause Primary Intrahepatic Cholangiocarcinoma
- (2012) M. R. O'Dell et al. CANCER RESEARCH
- Disruption of Trp53 in Livers of Mice Induces Formation of Carcinomas With Bilineal Differentiation
- (2012) Sarah–Fee Katz et al. GASTROENTEROLOGY
- Notch Signaling Is Activated in Human Hepatocellular Carcinoma and Induces Tumor Formation in Mice
- (2012) Augusto Villanueva et al. GASTROENTEROLOGY
- Constitutive Notch2 signaling induces hepatic tumors in mice
- (2012) Michael T. Dill et al. HEPATOLOGY
- Cholangiocarcinomas can originate from hepatocytes in mice
- (2012) Biao Fan et al. JOURNAL OF CLINICAL INVESTIGATION
- Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes
- (2012) Sayaka Sekiya et al. JOURNAL OF CLINICAL INVESTIGATION
- Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas
- (2012) P Wang et al. ONCOGENE
- Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors
- (2011) Jesper B. Andersen et al. GASTROENTEROLOGY
- AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2,
- (2011) Coral Ho et al. HEPATOLOGY
- Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping
- (2011) D. R. Borger et al. ONCOLOGIST
- Erratum: Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- (2010) Lenny Dang et al. NATURE
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started